https://www.selleckchem.com/pr....oducts/geldanamycin.
We sought to investigate stent healing and neointimal hyperplasia with ihtDEStiny drug-eluting stent (DES) by optical coherence tomography (OCT) examination conducted 9months after implantation. The currently used DES present certain features that have been linked separately to their better performance in terms of efficacy and safety. First-in-man, prospective and multicenter study including patients treated with ihtDEStiny stent undergoing OCT examination at 9months follow up. The ihtDEStiny stent is a sirolimus eluting stent with
Like
Comment
Share
